Skip to main content
NIH funding notice RFA-HL-15-030

Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)

Closed on July 20, 2017.

Posted
November 7, 2014
Close date
July 20, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,583,297 in first-year total cost, median $222,782.

Most frequent study sections

  1. Special Emphasis Panel[ZHL1 CSR-B (S1)]4
  2. Special Emphasis Panel[ZHL1 CSR-O (F1)]1

Most frequent institutions

  1. CELL PRESERVATION SERVICES, INC.2
  2. ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS1
  3. CELLOLOGI, LLC1
  4. HEADWATERS INNOVATION, INC.1
Competing awards under RFA-HL-15-030 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018The SmartBio System for the Improved Preservation of Human Hematopoietic Stem Cells2R44HL130805-02BAUST, JOHN MCELL PRESERVATION SERVICES, INC., NY$659,207ZHL1
2016The SmartBio System for the Improved Preservation of Human Hematopoietic Stem Cells1R43HL130805-01A1BAUST, JOHN MCELL PRESERVATION SERVICES, INC., NY$264,000ZHL1
2016Development of a microfludic device for removal of glycerol from cultured red blood cells1R43HL130123-01A1BISCHOFF, BRIAN JOHNHEADWATERS INNOVATION, INC., MN$222,782ZHL1
2016Adaptable and Automated Large-Scale Manufacturing of iPSC-Derived Cell Products1R43HL130814-01A1WANG, JIWUALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, CA$222,173ZHL1
2016Genetically Engineered Stem Cell Derived Blood1R43HL135295-01GEILER, CRISTOPHERCELLOLOGI, LLC, CA$215,135ZHL1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HL-15-030: Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44) | ScienceDex | ConductScience